Chuknyiska R S, Haji M, Foote R H, Roth G S
Endocrinology. 1984 Aug;115(2):836-8. doi: 10.1210/endo-115-2-836.
Estradiol injected in vivo successfully completes for binding to uterine nuclear acceptor sites measured by the assay of Kon and Spelsberg (1). Such competition is time-and dose-dependent, with maximal inhibition (75%) 1 h after injection and at a dose of 10 micrograms of 17 beta-estradiol per 300 g of BW. Thus, this assay appears to accurately measure those uterine nuclear acceptor sites mediating estrogen action in vivo.